we are focus for your future

CVasThera is a early clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for cardiovascular and bowel pathologies.

Some reasons to work together

The Company has an innovative and broad expertise on product candidates that it believes can overcome the deficiencies of current treatment options for a variety of cardiovascular and inflammatory diseases. We have several drugs in various stages of clinical investigation. Our lead drug candidate uses our proprietary formulation of the repositionning cardiovascular compound for the treatment of bowel pain and inflammation.

Current areas of therapeutic focus are: atrial fibrillation, post myocardial infarction remodelling, thrombotic diseases, bowel pain and crohn diseases

About CVasThera
CVasThera proposes a new approach in the valuation of biopharmaceutical R&D products. Based on a strong experience of founders, CVasThera invests in the valuation of projects by itself or through partnerships.